Literature DB >> 21528490

Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.

Elżbieta Kimak1, Magdalena Hałabiś, Iwona Baranowicz-Gąszczyk, Janusz Solski, Andrzej Książek.   

Abstract

Disturbances in the metabolism of lipoprotein profiles and oxidative stress in hemodialyzed (HD) and post-renal transplant (Tx) patients are proatherogenic, but elevated concentrations of plasma high-density lipoprotein (HDL) reduce the risk of cardiovascular disease. We investigated the concentrations of lipid, lipoprotein, HDL particle, oxidized low-density lipoprotein (ox-LDL) and anti-ox-LDL, and paraoxonase-1 (PON-1) activity in HD (n=33) and Tx (n=71) patients who were non-smokers without active inflammatory disease, liver disease, diabetes, or malignancy. HD patients had moderate hypertriglyceridemia, normocholesterolemia, low HDL-C, apolipoprotein A-I (apoA-I) and HDL particle concentrations as well as PON-1 activity, and increased ox-LDL and anti-ox-LDL levels. Tx patients had hypertriglyceridemia, hypercholesterolemia, moderately decreased HDL-C and HDL particle concentrations and PON-1 activity, and moderately increased ox-LDL and anti-ox-LDL levels as compared to the reference, but ox-LDL and anti-ox-LDL levels and PON-1 activity were more disturbed in HD patients. However, in both patient groups, lipid and lipoprotein ratios (total cholesterol (TC)/HDL-C, LDL-C/HDL-C, triglyceride (TG)/HDL-C, HDL-C/non-HDL-C, apoA-I/apoB, HDL-C/apoA-I, TG/HDL) were atherogenic. The Spearman's rank coefficient test showed that the concentration of ox-LDL correlated positively with HDL particle level (R=0.363, P=0.004), and negatively with TC (R=-0.306, P=0.012), LDL-C (R=-0.283, P=0.020), and non-HDL-C (R=-0.263, P=0.030) levels in Tx patients. Multiple stepwise forward regression analysis in Tx patients demonstrated that ox-LDL concentration, as an independent variable, was associated significantly positively with HDL particle level. The results indicated that ox-LDL and decreased PON-1 activity in Tx patients may give rise to more mildly-oxidized HDLs, which are less stable, easily undergo metabolic remodeling, generate a greater number of smaller pre-β-HDL particles, and thus accelerate reverse cholesterol transport, which may be beneficial for Tx patients. Further studies are necessary to confirm this.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528490      PMCID: PMC3087092          DOI: 10.1631/jzus.B1000348

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  19 in total

1.  Serum oxidized LDL is inversely associated with HDL2-cholesterol subclass in renal failure patients on hemodialysis.

Authors:  E Samouilidou; A Karpouza; E Grapsa; H Tzanatou-Exarchou
Journal:  Nephron Clin Pract       Date:  2010-04-28

2.  Oxidative stress and damage induced by abnormal free radical reactions and IgA nephropathy.

Authors:  Jia-xi Chen; Jun-fu Zhou; Han-chao Shen
Journal:  J Zhejiang Univ Sci B       Date:  2005-01       Impact factor: 3.066

3.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.

Authors:  Dragomir I Draganov; John F Teiber; Audrey Speelman; Yoichi Osawa; Roger Sunahara; Bert N La Du
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

4.  Effect of calcineurin inhibitors on low-density lipoprotein oxidation.

Authors:  F Cofan; M Cofan; B Campos; R Guerra; J-M Campistol; F Oppenheimer
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

5.  HDL2 can inhibit further oxidative modification of partially oxidized LDL.

Authors:  Nagahiko Sakuma; Tomoaki Saeki; Tatsuya Ito; Takeshi Hibino; Shogo Suzuki; Mitoshi Kunimatsu; Koji Yamamoto; Syuichi Kitada
Journal:  J Atheroscler Thromb       Date:  2009-11-27       Impact factor: 4.928

Review 6.  Atherogenic dyslipidemia and oxidative stress: a new look.

Authors:  Manfredi Rizzo; Jelena Kotur-Stevuljevic; Kaspar Berneis; Giatgen Spinas; Giovam Battista Rini; Zorana Jelic-Ivanovic; Vesna Spasojevic-Kalimanovska; Jelena Vekic
Journal:  Transl Res       Date:  2009-02-23       Impact factor: 7.012

7.  Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.

Authors:  Hamid Moradi; Madeleine V Pahl; Reza Elahimehr; Nosratola D Vaziri
Journal:  Transl Res       Date:  2008-12-10       Impact factor: 7.012

8.  Mild oxidation promotes and advanced oxidation impairs remodeling of human high-density lipoprotein in vitro.

Authors:  Xuan Gao; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

9.  Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux.

Authors:  Angela Pirillo; Patrizia Uboldi; Gianluca Pappalardo; Hartmut Kuhn; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

10.  Effect of HDL composition and particle size on the resistance of HDL to the oxidation.

Authors:  Nakanishi Shuhei; Sanni Söderlund; Matti Jauhiainen; Marja-Riitta Taskinen
Journal:  Lipids Health Dis       Date:  2010-09-23       Impact factor: 3.876

View more
  3 in total

1.  Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation.

Authors:  Hossein Tabriziani; Michael S Lipkowitz; Nhan Vuong
Journal:  Clin Kidney J       Date:  2017-08-16

2.  Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.

Authors:  Elżbieta Kimak; Jerzy Bylina; Janusz Solski; Magdalena Hałabiś; Iwona Baranowicz-Gąszczyk; Andrzej Książek
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

3.  Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.

Authors:  Elżbieta Kimak; Bartosz Zięba; Dariusz Duma; Janusz Solski
Journal:  Lipids Health Dis       Date:  2018-04-04       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.